The FDA has approved ocrelizumab for treating relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.
Andrew Gentry, PharmD
Advertisement
Andrew Gentry, PharmD is a PGY-1 pharmacy resident at John Dempsey Hospital/UConn Health, Farmington, CT.
Articles by Andrew Gentry, PharmD
Advertisement
Latest Updated Articles
- Ocrelizumab for Multiple Sclerosis
Published: August 14th 2017 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Shifting from Reactive to Proactive Diabetes Counselors
2
Naloxone Sales Highlight Limited OTC Use, Access Challenges
3
Is it Safe for Birth Control Users to Go Years Without a Period?
4
Investigators Evaluate Decline in Percentage of Patients With COPD Using Inhaled Corticosteroids
5
